| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $184.75M | $65.32M | $85.31M | $35.55M | $102.32M | $42.45M |
| EPS (basic) | – | 0.7600 | 0.6300 | 1.1100 | 0.4500 | 0.5400 |
| EPS (diluted) | – | 0.7600 | 0.6300 | 1.1100 | 0.4500 | 0.5400 |
| Shares (diluted) | $38.71M | $36.74M | $34.47M | $33.31M | $33.21M | $33.18M |